OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
October 02, 2011
The authors examine risk management relating to the quality issues of clinical-trial materials and discuss areas that would benefit from additional consideration and harmonization.
CROs that have made big acquisitions could be outmaneuvered by evolving sourcing models.
A Q&A with Rao Tatapudy, vice-president of scientific affairs at Catalent, on recent industry trends.
Letting contamination build up can cause multiple headaches.
In an effort to balance bilateral trade, India is urging China to increase Indian pharmaceutical imports.
Manufacturers fund research and reduce prices to tackle diseases.
The global excipients market shows moderate growth, increased consolidation, and expansion activity in emerging markets and select product areas.
October 01, 2011
With the Western world recovering slowly from a recession, and tighter restrictions for medical products being applied by the FDA and other regulatory authorities, more medical device R&D is being located in Asia.
The contract services industry is a crowded market and it's important for companies to differentiate themselves to stand out.
The past year has seen significant consolidation of mid-size CROs, with many of them being bought or put up for sale. In particular, the top six or seven CROs seem to be signing more preferred partner deals, such as Pfizer teaming with Parexel and ICON, and Takeda?s deals with Covance and Quintiles, which is driving mid-size CROs growth through major acquisitions.